Literature DB >> 1775193

Effects of diazepam on nociception in rats.

F Zambotti1, N Zonta, R Tammiso, F Conci, B Hafner, L Zecca, P Ferrario, P Mantegazza.   

Abstract

Acute i.p. injection of diazepam (1 mg/kg) resulted in a moderate increase in the tail-flick latency in rats. Tolerance to this diazepam effect developed after 10 days of diazepam treatment (1 mg kg-1 day-1). The benzodiazepine antagonist Ro 15-3505 only partially reversed the effect of diazepam on nociception. Naloxone (5 mg/kg i.p.) failed to affect the effect of diazepam on nociception, while the kappa antagonist MR 2266 fully antagonized the diazepam-induced increase of the tail-flick latency. Diazepam injected intracerebroventricularly (1, 5, 20 micrograms/rat) did not alter basal nociceptive threshold, however, diazepam injected intrathecally (20 micrograms/rat) prolonged the tail-flick latency. Furthermore, intracerebroventricular injection of muscimol partially antagonized the i.p. diazepam-induced increase of the tail-flick latency. These results suggest that benzodiazepine receptor sites are partially involved in the effect of diazepam on nociception and indicate that an indirect kappa-opioid-receptor-mediated mechanism may be involved. The anatomical site of diazepam action on tail-flick latency seems to be at the spinal level. Descending axons to the spinal cord from brain areas reached by intracerebroventricular injection of muscimol seem to modulate the effect of diazepam effect on nociception.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775193     DOI: 10.1007/bf00167386

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Rat tail flick acupuncture analgesia model.

Authors:  R Minfeng; H Jisheng
Journal:  Chin Med J (Engl)       Date:  1979-08       Impact factor: 2.628

2.  A simple and inexpensive cannula technique for chemical stimulation of the brain.

Authors:  F B Altaffer; F S Verster; S Hall; C J Long; P D'encarnacao
Journal:  Physiol Behav       Date:  1970-01

3.  Analgesic and hyperalgesic effects of midazolam: dependence on route of administration.

Authors:  D Niv; S Davidovich; E Geller; G Urca
Journal:  Anesth Analg       Date:  1988-12       Impact factor: 5.108

4.  Effects of an intrathecally administered benzodiazepine receptor agonist, antagonist and inverse agonist on morphine-induced inhibition of a spinal nociceptive reflex.

Authors:  J L Moreau; L Pieri
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

5.  Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.

Authors:  A E Panerai; A Martini; P Sacerdote; P Mantegazza
Journal:  Brain Res       Date:  1984-06-18       Impact factor: 3.252

6.  Modification of the antinociceptive effect of morphine by centrally administered diazepam and midazolam.

Authors:  P Mantegazza; M Parenti; R Tammiso; P Vita; F Zambotti; N Zonta
Journal:  Br J Pharmacol       Date:  1982-04       Impact factor: 8.739

7.  Unexpected opioid activity in a known class of drug.

Authors:  D Römer; H H Büscher; R C Hill; R Maurer; T J Petcher; H Zeugner; W Benson; E Finner; W Milkowski; P W Thies
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

8.  Chronic catheterization of the spinal subarachnoid space.

Authors:  T L Yaksh; T A Rudy
Journal:  Physiol Behav       Date:  1976-12

9.  Blockade of non-opioid analgesia in intruder mice by selective neuronal and non-neuronal benzodiazepine recognition site ligands.

Authors:  R J Rodgers; J I Randall
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Effects of some GABA-mimetic drugs on the antinociceptive activity of morphine and beta-endorphin in rats.

Authors:  N Zonta; F Zambotti; L Vicentini; R Tammiso; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

View more
  8 in total

1.  Effects of acute administration of nicotine, amphetamine, diazepam, morphine, and ethanol on risky decision-making in rats.

Authors:  Marci R Mitchell; Colin M Vokes; Amy L Blankenship; Nicholas W Simon; Barry Setlow
Journal:  Psychopharmacology (Berl)       Date:  2011-06-03       Impact factor: 4.530

Review 2.  GABA pharmacology: the search for analgesics.

Authors:  Kenneth E McCarson; S J Enna
Journal:  Neurochem Res       Date:  2014-02-15       Impact factor: 3.996

3.  Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain.

Authors:  Alexandre J Parent; Nicolas Beaudet; Hélène Beaudry; Jenny Bergeron; Patrick Bérubé; Guy Drolet; Philippe Sarret; Louis Gendron
Journal:  Behav Brain Res       Date:  2012-01-08       Impact factor: 3.332

4.  The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys.

Authors:  Christopher A Podlesnik; Mei-Chuan Ko; Gail Winger; Jürgen Wichmann; Eric P Prinssen; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2010-09-18       Impact factor: 4.530

5.  Low and high doses of midazolam differentially affect hypoalgesia in rats conditioned to a heat stressor.

Authors:  J A Harris; I S McGregor; R F Westbrook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Attenuation of reperfusion hyperalgesia in the rat by systemic administration of benzodiazepines.

Authors:  S M Cartmell; D Mitchell
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

Review 7.  Normalization of Neuroinflammation: A New Strategy for Treatment of Persistent Pain and Memory/Emotional Deficits in Chronic Pain.

Authors:  Xian-Guo Liu
Journal:  J Inflamm Res       Date:  2022-09-09

8.  Positive allosteric modulators of nonbenzodiazepine γ-aminobutyric acidA receptor subtypes for the treatment of chronic pain.

Authors:  Timothy B C Johnstone; Jennifer Y Xie; Chaoling Qu; David J Wasiak; Derk J Hogenkamp; Frank Porreca; Kelvin W Gee
Journal:  Pain       Date:  2019-01       Impact factor: 7.926

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.